| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Are We Losing Our Competitive Advantage? |
|
Advice You - Are We Losing Our Competitive Advantage?
Working in the United States has become increasingly competitive. It has been a very challenging time for most According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Americans. We are facing an international labor market that is highly skilled, competitive and eager to take t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eir place in the international marketplace. On a daily basis we read stories about how American corporations a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. re: · Sending work overseas to China and India · Laying off employees by the thousands · Cutting emp here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe oyee benefits · Demanding salary pay-cuts · Hiring foreign workers instead of Americans · Increa d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro sing corporate mergers · Demanding work schedules · And many more… Why are Americans becoming less c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc mpetitive? The reasons are simple: 1. Lack of math and science training 2. Lack of understanding market easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi chances 3. Lack of information 4. Poor communication skills 5. Failure to relocate 6. Poor nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ajor and course selection 7. Poor networking 8. Failure to seek extra credentials/certifications and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ 9. Be supportive of your colleagues 10. Going the extra mile During a recent visit to Mainland China and ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi SE Asia I came into contact with several Americans. I wondered why they were working in China and not the Unit ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ed States? In a nutshell: Competitive Advantage! How do I Become Competitive? 1. Maintain the right perspect dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ve (this is something that can be solved) a. Look beyond the problem and see the provision b. Attitud cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e needs to be change 2. Identify the problem a. The power to define is to determine the destiny tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Use your head - think Keeping Your Word “When people promise me something, I believe they will do what they t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel say and make note of their promise. At that point if they say they are not going to follow through on what the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust promised, I ease from my mind the promise they made. Though disappointed, the fulfilling of the promise rests y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products in their hands, so I release them from it and do not hold it against them. Doing this constantly encourages me . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o be a man of my word.” - Paul J. Meyer, New York Times Best Selling Author If you want to be competitive you elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Dangers of Contract Negotiations With Non-English Speaking Consumers Tips on Picking the Best Accounting Software - Top 2 Picks Finding the Top Home Based Businesses
|